Yange Tian Selected Research

paeonol

1/2022	Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway.
1/2021	The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD.
7/2020	Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yange Tian Research Topics

Disease

44	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 01/2014
15	Inflammation (Inflammations) 02/2024 - 01/2017
12	Bacterial Infections (Bacterial Infection) 10/2023 - 01/2015
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2024 - 01/2023
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2023 - 03/2015
3	Silicosis 07/2023 - 02/2023
3	Airway Remodeling 12/2022 - 11/2021
2	Wounds and Injuries (Trauma) 10/2023 - 11/2021
2	Hypertrophy 01/2016 - 01/2015
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2024
1	Acute Lung Injury 02/2024
1	Acute-Phase Reaction 10/2023
1	Asthma (Bronchial Asthma) 09/2023
1	Cough 09/2023
1	Pneumonia (Pneumonitis) 06/2023
1	Fibrosis (Cirrhosis) 02/2023
1	Vascular Remodeling 01/2022

Drug/Important Bio-Agent (IBA)

24	Bu-Fei-Yi-ShenIBA 02/2024 - 01/2014
19	SmokeIBA 11/2023 - 01/2015
16	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2015
11	CytokinesIBA 12/2023 - 01/2015
8	Therapeutic UsesIBA 09/2023 - 01/2014
8	bufei jianpiIBA 12/2022 - 01/2015
6	Messenger RNA (mRNA)IBA 09/2023 - 01/2019
6	CollagenIBA 06/2023 - 01/2016
5	AntioxidantsIBA 10/2023 - 01/2016
5	icariinIBA 01/2023 - 07/2020
5	nobiletinIBA 01/2023 - 07/2020
5	InterleukinsIBA 01/2022 - 01/2014
4	LipopolysaccharidesIBA 02/2024 - 01/2022
4	NF-kappa B (NF-kB)IBA 01/2022 - 01/2019
4	Aminophylline (Carine)FDA LinkGeneric 01/2019 - 03/2015
3	Interleukin-6 (Interleukin 6)IBA 07/2023 - 01/2019
3	paeonolIBA 01/2022 - 07/2020
3	Peptide Hydrolases (Proteases)FDA Link 07/2020 - 01/2016
3	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2015
3	Oxidoreductases (Dehydrogenase)IBA 06/2017 - 01/2016
2	OccludinIBA 02/2024 - 09/2023
2	Cadherins (E-Cadherin)IBA 02/2024 - 09/2023
2	Sirtuin 1IBA 02/2024 - 01/2022
2	Adenosine Triphosphate (ATP)IBA 12/2023 - 01/2019
2	Acetylcysteine (Siran)FDA LinkGeneric 10/2023 - 01/2022
2	Silicon Dioxide (Silica)FDA LinkGeneric 06/2023 - 02/2023
2	Mitogen-Activated Protein KinasesIBA 06/2023 - 01/2021
2	Mechanistic Target of Rapamycin Complex 2IBA 04/2022 - 11/2021
2	ginsenoside Rh1IBA 01/2022 - 01/2021
2	Interleukin-4 (Interleukin 4)IBA 01/2022 - 01/2020
2	Saline SolutionIBA 01/2022 - 01/2019
2	Particulate MatterIBA 11/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2019
2	p38 Mitogen-Activated Protein KinasesIBA 03/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2015
2	Arachidonic Acid (Vitamin F)IBA 06/2017 - 01/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2024
1	ethyl acetateIBA 02/2024
1	Glycogen Synthase KinasesIBA 12/2023
1	InflammasomesIBA 12/2023
1	Glutathione (Reduced Glutathione)IBA 10/2023
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2023
1	C-Reactive ProteinIBA 10/2023
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 09/2023
1	SuspensionsIBA 07/2023
1	InterferonsIBA 06/2023
1	RNA (Ribonucleic Acid)IBA 02/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	verticineIBA 01/2023
1	peoniflorinIBA 01/2023
1	isoliquiritigenin (GU 17)IBA 01/2023
1	12- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA 01/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2023
1	SphingolipidsIBA 01/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2023
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2023
1	Poly I-CIBA 12/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	quxieIBA 11/2021
1	Phosphotransferases (Kinase)IBA 03/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	Plant ExtractsIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	GinsenosidesIBA 07/2020
1	astragaloside AIBA 07/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020

Therapy/Procedure

10	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2024 - 01/2015
10	Therapeutics 01/2022 - 01/2014
4	Oral Administration 03/2024 - 01/2017
3	Electroacupuncture 01/2022 - 01/2019
3	Acupuncture Points (Acupuncture Point) 01/2017 - 08/2015
1	Exercise Therapy (Therapy, Exercise) 11/2023